Sentence examples for 0.5 compared from inspiring English sources

Adult rams mounted more (21.7 ± 4.5 compared with 9.8 ± 0.7) and tended to ejaculate more frequently (2.9 ± 0.5 compared with 1.8 ± 0.4) than yearling rams.

A single ip injection of recombinant rat leptin after overnight fasting increased serum leptin levels (ng/ml; Mean ± SE) by ~4 fold in DIO rats (8.26 ± 1.9) and produced a 2-fold increase in DR rats (4.23 ± 0.5) compared to saline-treated controls (1.8 ± 0.3 and 1.2 ± 0.1 in DIO and DR respectively; Fig. 1a).

Fluorescence was measured as mean fluorescence intensity (MFI), and tumor-to-background ratios (TBRs) were calculated by comparing MFIs of tumor and histologically uninvolved tissue.The mean TBR was significantly higher in tumor tissue of contrast-enhancing (CE) tumors on preoperative imaging (4.0 ± 0.5) compared to non-CE tumors (1.2 ± 0.3; p = 0.02).

This may be due to the greater amount of H2O in the basalt composition used in this study (0.5 compared to 0.2 wt% in the earlier study).

The lower limit (M4.0) of the analyzed earthquakes was fixed in order to maintain a difference in magnitude of 0.5 compared to the EGFs and to ensure quality in estimating the corner frequencies.

However, Pielou evenness was not significantly different between piospheres (F = 3.05, P = 0.052) but was higher at 20 m near the dam (0.8 ± 0.5) compared to a similar distance from the trough (0.7 ± 0.1) and the river (0.7 ± 0.1).

Using a 1 160 scale model it was shown that the Tower causes a small deflection (ca. 0.5°) compared to the lattice on top on which the instruments were placed (ca. 0 4°).

Each gas sample was analyzed twice, with an analytical precision of ±0.5‰ compared with the Vienna Pee Dee Belemnite (VPDB) standard.

One of the major differences observed is the low level of the genus Bacteroides in A-V4-0.5 and B-V4-0.5 compared with D-V4-0.5.

This pronounced pro-inflammatory effect of 10% HES 200/0.5 compared with 6% HES 130/0.42 caused more tubular damage than 6% HES 130/0.42 and RL [ 12].

24 At week 24, 91.0% of adalimumab-treated patients had no radiographic progression (mTSS change ⩽0.5) compared with 71.1% of placebo-treated patients.